TrialThe oncologist2020

D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer.

Vaibhav Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.